Table 3.
Predictors of overall survival and progression-free survival after abscopal response
| Univariate hazard ratio | 95% CI | P value | Multivariate hazard ratio | 95% CI | P value | |
|---|---|---|---|---|---|---|
| Overall survival | ||||||
| Surgery | ||||||
| No | Ref | Ref | Ref | Ref | Ref | Ref |
| Yes | 0.9 | 0.12-7.60 | .96 | 1.16 | 0.11-12.13 | .9 |
| Chemotherapy | ||||||
| No | Ref | Ref | Ref | Ref | Ref | Ref |
| Yes | 0.63 | 0.08-5.01 | .66 | 0.46 | 0.04-4.79 | .51 |
| Immunotherapy | ||||||
| No | Ref | Ref | Ref | Ref | Ref | Ref |
| Yes | 0.68 | 0.14-3.22 | .63 | 0.6 | 0.12-2.92 | .52 |
| BED 10 Gy increase | 0.99 | 0.96-1.01 | .29 | 0.99 | 0.96-1.01 | .3 |
| Progression-free survival | ||||||
| Surgery | ||||||
| No | Ref | Ref | Ref | Ref | Ref | Ref |
| Yes | 0.46 | 0.06-3.57 | .46 | 3.7 × 10^-9 | 0-Inf | .99 |
| Chemotherapy | ||||||
| No | Ref | Ref | Ref | Ref | Ref | Ref |
| Yes | 0.32 | 0.04-2.42 | .27 | 0.93 | 0.11-7.73 | .95 |
| Immunotherapy | ||||||
| No | Ref | Ref | Ref | Ref | Ref | Ref |
| Yes | 1.97 | 0.70-5.59 | .2 | 1.21 | 0.39-3.80 | .74 |
| BED 10 Gy increase | 0.99 | 0.98-1.01 | .42 | 0.99 | 0.98-1.01 | .36 |
Abbreviations: BED = biologically effective dose; CI = confidence interval; Ref = reference value.